Key result
Bailout covered stenting successfully seals refractory Dunning type III iatrogenic aortic dissection.
Why the study?
Iatrogenic aortocoronary dissection is an uncommon but potentially life-threatening complication of PCI.
Does a covered stent improve outcomes in patients with iatrogenic aortocoronary dissection refractory to drug-eluting stents?
Case Report (n=1)
No
Does a covered stent improve outcomes in patients with iatrogenic aortocoronary dissection refractory to drug-eluting stents?
Covered stents provide a definitive mechanical barrier and life-saving bailout strategy for severe PCI-induced iatrogenic aortocoronary dissection refractory to conventional stents.
May offer bailout option in refractory iatrogenic aortic dissection; single case leaves open need for prospective validation.
Background Iatrogenic aortocoronary dissection (IACD) is an uncommon but potentially life-threatening complication of percutaneous coronary intervention (PCI). Case summary We report the case of a 64-year-old male who developed IACD (Dunning type II) during PCI of right coronary artery. Initial bailout with drug-eluting (DSE) stents implantation but failed to completely exclude a retrograde tear into the aortic root. A larger covered stent (CS) was successfully deployed at the ostium halting the progression of the aortic dissection. Conclusion This case highlights that for PCI-induced IACD refractory to conventional DES, a CS provides a definitive barrier to halt dissection. A prompt percutaneous bailout, reinforced by strict hemodynamic control and surgical standby, is crucial for managing this catastrophic complication.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) conducted a case report in Iatrogenic aortocoronary dissection (IACD) (n=1). Covered stent was evaluated on Sealing of the dissection entry tear and halting of dissection progression. A covered stent successfully sealed the entry tear and halted the progression of a Dunning type III iatrogenic aortic dissection refractory to conventional drug-eluting stents.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: